¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"VAC"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 14 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • vacuolation
    °øÆ÷Çü¼º, °øÆ÷È­
  • vacuole
    °øÆ÷
  • vacuolization
    °øÆ÷Çü¼º, °øÆ÷È­
  • vacutainer tube
    Áø°øÃ¤Ç÷°ü, ¹èÅ¥Å×À̳ʰü
  • vacuum
    Áø°ø
  • vacuum casting
    Áø°øÁÖÁ¶
  • vacuum chamber
    Áø°ø½Ç
  • vacuum dehydration
    Áø°øÅ»¼ö, Áø°ø°ÇÁ¶
  • vacuum distillation
    Áø°øÁõ·ù
  • vacuum extraction
    ÈíÀԺи¸, Áø°øºÐ¸¸
  • vacuum headache
    Áø°øµÎÅë
  • vacuum investing
    Áø°ø¸Å¸ô
  • vacuum suction
    Áø°øÈíÀÎ
  • vacuum tube
    Áø°ø°ü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • vaccinoid reaction
    ¹é½Å¸ð¾ç¹ÝÀÀ
  • vaccinola
    (¢¡generalized vaccinia) Àü½Å¿ìµÎ
  • vacuolar
    °øÆ÷-
  • vacuolar degeneration
    °øÆ÷º¯¼º
  • vacuolar myelopathy
    °øÆ÷ô¼öº´Áõ
  • vacuolation
    °øÆ÷Çü¼º
  • vacuole
    °øÆ÷
  • vacuolization
    (¢¡vacuolation) °øÆ÷Çü¼º
  • vacutainer tube
    Áø°øÃ¤Ç÷°ü, ¹èÅ¥Å×À̳ʰü
  • vacuum
    Áø°ø
  • vacuum casting
    Áø°øÁÖÁ¶
  • vacuum chamber
    Áø°ø½Ç
  • vacuum cooling
    Áø°ø³Ã°¢
  • vacuum dehydration
    Áø°øÅ»¼ö, Áø°ø°ÇÁ¶
  • vacuum distillation
    Áø°øÁõ·ù
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • vaccine therapy
    ¹é½Å¿ä¹ý(¡­èþÛö).
  • vaccine therapy
    ¹é½Å¿ä¹ý(¡­èþÛö).
  • vaccine, attenuated
    ¾àµ¶[È­] ¹é½Å
  • vaccine, inactivated virus
    ºÒȰ¼ºÈ­ ¹ÙÀÌ·¯½º ¹é½Å
  • vaccine, killed
    »ç¸ê¹é½Å
  • vaccine, live
    »ý¹é½Å
  • vaccine, monovalent
    Àϰ¡ (ìéʤ) ¹é½Å
  • vaccine, polyvalent
    ´Ù°¡ (Òýʤ) ¹é½Å
  • vaccine, subunit
    ¾Æ´ÜÀ§ ¹é½Å
  • vaccinia bovis ³ª
    ¿ìµÎ¹é½Å.
  • vaccinia gangrenosum ³ª
    ±«Àú¼º ¹é½Ã´Ï¾Æ.
  • vaccinia necrosum
    ±«»ç¼º Á¾µÎÁõ.
  • vaccinia necrosum
    ³ª ±«»ç¼º Á¾µÎÁõ.
  • vaccinia necrosum ³ª
    ±«»ç¼º Á¾µÎÁõ.
  • vaccinia virus
    ¿ìµÎ¹ÙÀÌ·¯½º.
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • vaccinization
    Á¾µÎÈ­, ¿ÏÀü Á¾µÎ¹ý
  • vaccinogenous
    ¹é½Å »ý»ê¼º
    ¹é½ÅÀ» ¸¸µå´Â.
  • vaccinoid reaction
    °¡µÎ¼º ¹ÝÀÀ
  • vaccinophobia
    Á¾µÎ °øÆ÷, Á¾µÎ°øÆ÷Áõ
  • vaccinotherapy
    ¹é½Å ¿ä¹ý
    ¹é½ÅÀ» Ä¡·á ¸ñÀûÀ¸·Î ÀÌ¿ëÇÏ´Â °Í.
  • vacuolar
    °øÆ÷ÀÇ, °øÆ÷¼ºÀÇ
    °øÆ÷ÀÇ Á¸Àç°¡ Ư¡ÀûÀÎ.
  • vacuolar myelopathy
    °øÆ÷¼º ô¼öº´Áõ
  • vacuolate
    °øÆ÷È­ÇÏ´Ù
    ÀÛÀº °£°Ý ȤÀº °øÆ÷¸¦ Çü¼ºÇÏ´Ù.
  • vacuolated virus
    °øÆ÷¼º ¹ÙÀÌ·¯½º
  • vacuole
    °øÆ÷, ¾×Æ÷, ¼ÒÆ÷
    ¼¼Æ÷ÀÇ ¿øÇüÁú ³»¿¡ Çü¼ºµÈ ÀÛÀº °£±ØÀ̳ª ¼ÒÆ÷.
  • vacuome
    Áß¼ºÀû °øÆ÷, ¹ÙÄí¿È
    ¼¼Æ÷ ³»¿¡ Áß¼ºÀ¸·Î ¿°»öµÇ´Â °øÆ÷°è.
  • vacuum
    Áø°ø
    Áø°ø, °ø±â ¶Ç´Â ´Ù¸¥ °¡½º¸¦ ¹èÃâÇÑ °ø°£, °ø±â ¶Ç´Â °¡½º°¡ ¾ø´Â °ø°£.
  • vacuum baking
    Áø°ø ¼Ò¼º
    µµÀç ¼Ò¼º¿¡´Â Áø°ø ¼Ò¼º°ú º¸Åë ¼Ò¼º¹ýÀÌ Àִµ¥ Áø°ø ¼Ò¼ºÀº furnace ³»ºÎ¸¦ Áø°ø ÆßÇÁ·Î °¨¾ÐÇϸ鼭 Áø°øÇÏ¿¡¼­ ¼Ò¼ºÇÏ´Â °ÍÀ¸·Î µµÀçÀÇ ³»ºÎ¿¡ ±âÆ÷°¡ »ý±âÁö ¾Ê°í °ß°íÇÏ¸ç ¾Æ¸§´Ù¿î µµÀ縦 Á¦ÀÛÇÒ ¼ö ÀÖ´Â ¼Ò¼º¹ýÀÌ´Ù.
  • vacuum casting
    Áø°ø ÁÖÁ¶
    Áø°ø »óÅ¿¡¼­ ±Ý¼ÓÀ» ÁÖÁ¶ÇÏ´Â °Í.
  • vacuum chamber
    Áø°ø½Ç
    Áø°ø »óÅÂÀÇ °¡¿­°­À» °¡¸®Å²´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
vaccination, hepatitis a When immediate protection against hepatitis a (infectious hepatitis) is needed, immunoglobulins are used. Protection is effective only if given within 2 weeks of exposure and lasts but 2-4 months. Immunoglobulins can be used to protect household contacts of someone with acute viral hepatitis and travelers to regions with poor sanitation and high hepatitis a rates, when the traveler has to depart sooner than the vaccines can take effect (about 2 weeks). Travelers can receive the immunoglobulin and vaccine simultaneously and be protected immediately and for longer term. When immediate protection is not needed, hepatitis a vaccines are considered for individuals in high-risk settings, including frequent world travelers, sexually active individuals with multiple partners, homosexual men, individuals using illicit drugs, employees of daycare centres, and certain health care workers, and sewage workers. Two hepatitis a vaccines called havrix and vaqta are commercially available in the u.s. Both are highly effective and provide protection even after only one dose. Two doses are recommended for adults and 3 doses for children (under 18 years of age) to provide prolonged protection.
(12 Dec 1998)
vaccination, hepatitis b Hepatits B (hep B) vaccine gives prolonged protection, but 3 shots over a half year are usually required. In the u.s., all infants receive hep b vaccine. Two vaccines (engerix-b, and recombivax-hb) are available in the us. The first dose of hep b vaccine is frequently given while the newborn is in the hospital or at the first doctor visit following birth. The second dose is given about 30 days after the initial dose. A booster dose is performed approximately six months later. Babies born to mothers testing positive for hep b receive, in addition, hbig (hep b immune globulin) for prompt protection. Older children (11-12 years) are advised to receive a hep b booster as are adults in high-risk situations including healthcare workers, dentists, intimate and household contacts of patients with chronic hep b infection, male homosexuals, individuals with multiple sexual partners, dialysis patients, iv drug users, and recipients of repeated transfusions. Health care workers accidentally exposed to materials infected with hep b (such as needle sticks), and individuals with known sexual contact with hep b patients are available in the u.s. Both are highly effective and provide protection even after only one dose. Two doses are recommended for adults and 3 doses for children (under 18 years of age) to provide prolonged protection. Vaccination, hepatitis b: hepatits b (hep b) vaccine gives prolonged protection, but 3 shots over a half year are usually required. In the u.s., all infants receive hep b vaccine. Two vaccines (engerix-b, and recombivax-hb) are available in the us. The first dose of hep b vaccine is frequently given while the newborn is in the hospital or at the first doctor visit following birth. The second dose is given about 30 days after the initial dose. A booster dose is performed approximately six months later. Babies born to mothers testing positive for hep b receive, in addition, hbig (hep b immune globulin) for prompt protection. Older children (11-12 years) are advised to receive a hep b booster as are adults in high-risk situations including healthcare workers, dentists, intimate and household contacts of patients with chronic hep b infection, male homosexuals, individuals with multiple sexual partners, dialysis patients, iv drug users, and recipients of repeated transfusions. Health care workers accidentally exposed to materials infected with hep b (such as needle sticks), and individuals with known sexual contact with hep b patients are usually given both hbig and vaccine to provide immediate and long term protection.
(12 Dec 1998)
vaccination, hib This vaccine is to prevent disease caused by the haemophilus influenzae type b (hib) bacteria. The h. Influenzae (h. Flu) bacteria can cause a range of serious diseases including meningitis with potential brain damage and epiglottitis with airway obstruction poisoning. The hib vaccine is usually given at 2, 4 and 6 months of age. A final booster is given at 12-15 months of age. Hib vaccine rarely causes severe reactions.
(12 Dec 1998)
vaccination, infectious hepatitis See Vaccination, hepatitis a.
(12 Dec 1998)
vaccination, measles See Vaccination, MMR. Vaccination, mmr: the standard vaccine given to prevent measles, mumps and rubella (german measles). The mmr vaccine is now given in two dosages. The first should be given at12-15 months of age. The second vaccination hould be given at 4-6 years (or, alternatively, 11-12 years) of age. most colleges require proof of a second measles or mmr vaccination prior to entrance. Most children should receive mmr vaccinations. Exceptions may include children born with an inability to fight off infection, some children with cancer, on treatment with radiation or drugs for cancer, on long term steroids (cortisone). People with severe allergic reactions to eggs or the drug neomycin should probably avoid the mmr vaccine. Pregnant women should wait until after delivery before being immunised with mmr. People with HIV or aids should normally receive mmr vaccine. Measles, mumps, and rubella vaccines may be administered as individual shots, if necessary, or as a measles-rubella combination.
(12 Dec 1998)
vaccination, mumps See Vaccination, MMR. Vaccination, pneumococcal pneumonia: this vaccine, which prevents one of the most common and severe forms of pneumonia, is usually given only once in a lifetime, usually after the age of 55, to someone with ongoing lung problems (such as chronic obstructive pulmonary disease (copd) or asthma) or other chronic diseases (including those involving the heart and kidneys). This vaccination would rarely be given to children.
(12 Dec 1998)
vaccination, polio The vaccines available for vaccination against polio are opv (oral polio vaccine) and ipv (inactivated polio vaccine). Opv is still the preferred vaccine for most children. As its name suggests, it is given by mouth. Ipv, or inactivated polio vaccine is given as a shot in the arm or leg. Infants and children should be given four doses of opv. The doses are given at 2 months, 4 months, 6-18 months and 4-6 years of age. Persons allergic to eggs or the drugs neomycin or streptomycin should receive opv, not the injectable ipv. Conversely, ipv should be given if the vaccine recipient is on long-term steroid (cortisone) therapy, has cancer, or is on chemotherapy or if a household member has aids or there is an unimmunised adult in the house.
(12 Dec 1998)
vaccination, rubella See Vaccination, MMR.
(12 Dec 1998)
vaccination, varicella zoster See Vaccineation, chickenpox.
(12 Dec 1998)
vaccinator 1. A person who vaccinates.
Synonym: vaccinist.
2. A scarifier or other instrument used in vaccination.
(05 Mar 2000)
vaccine <pharmacology> A suspension of attenuated or killed microorganisms (bacteria, viruses or rickettsiae), administered for the prevention, amelioration or treatment of infectious diseases.
Origin: L. Vaccinus
(18 Nov 1997)
vaccine bodies Old term pertaining to intracellular body's that were erroneously thought to be forms in the life cycle of a protozoan organism, Cytorrhyctes vaccinae, postulated to be the causal agent of vaccinia.
(05 Mar 2000)
vaccine lymph Vaccinia lymph, that collected from the vesicles of vaccinia infection, and used for active immunization against smallpox.
(05 Mar 2000)
vaccine, flu The flu (influenza) vaccine is recommended for persons at high risk for serious complications from influenza infection, including everyone 65 or over; people with chronic diseases of the heart, lung or kidneys, diabetes, immunosuppression, or severe forms of anaemia; residents of nursing homes and other chronic-care facilities, children and teenagers taking aspirin therapy (and who may therefore be at risk for developing reye syndrome after an influenza infection), and those in close or frequent contact with anyone at high risk. Persons with an allergy to eggs should not receive influenza vaccine.
(12 Dec 1998)
vaccine, influenza See Vaccine, flu. Vaccination, dtap: like dpt, dtap protects from diphtheria, pertussis (whooping cough) and tetanus. Dtap is the same as dtp, except that it contains only acellular pertussis vaccine which is thought to cause fewer of the minor reactions associated with immunization and is also probably less likely to cause the more severe reactions occasionally seen following pertussis vaccination. Dtap is currently recommended only for the shots given at 18 months and 4-6 years of age. Vaccination, dt: dt (diphtheria and tetanus) vaccine does not protect from pertussis and is usually reserved for individuals who have had a significant adverse reaction to a dpt shot or who have a personal or family history of a seizure disorder or brain disease.
(12 Dec 1998)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 5 ÆäÀÌÁö: 2
  • Vaccines, Combined - »õâ Two or more vaccines in a single dosage form.
    Synonyms : Vaccines, Combination, Combination Vaccines, Combined Vaccines
  • Vaccines, Conjugate - »õâ Semisynthetic vaccines consisting of polysaccharide antigens from microorganisms attached to protein carrier molecules. The carrier protein is recognized by macrophages and T-cells thus enhancing immunity. Conjugate vaccines induce antibody formation in people not responsive to polysaccharide alone, induce higher levels of antibody, and show a booster response on repeated injection.
    Synonyms : Conjugate Vaccines
  • Vaccines, Contraceptive - »õâ Vaccines or candidate vaccines used to prevent conception.
    Synonyms : Antifertility Vaccines, Vaccines, Antifertility
  • Vaccines, DNA - »õâ Recombinant DNA vectors encoding antigens administered for the prevention or treatment of disease. The host cells take up the DNA, express the antigen, and present it to the immune system in a manner similar to that which would occur during natural infection. This induces humoral and cellular immune responses against the encoded antigens. The vector is called naked DNA because there is no need for complex formulations or delivery agents; the plasmid is injected in saline or other buffers.
    Synonyms : DNA Vaccines, Naked, DNA Vaccines, Recombinant, Vaccines, Naked DNA, Vaccines, Nucleic Acid, Vaccines, Polynucleotide
  • Vaccines, Edible - »õâ Vaccines or candidate vaccines derived from edible plants. Transgenic plants (PLANTS, TRANSGENIC) are used as recombinant protein production systems and the edible plant tissue functions as an oral vaccine.
    Synonyms : Edible Vaccines
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 5 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 4 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 10 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
Ÿ°Õ¿¡ÇÁ¿¬Áúĸ½¶ - »õâ
±¹Á¦¾àǰ°ø¾÷
A03005841 Vaccinium myrtillus extract
ÀϹÝÀǾàǰ | ±Þ¿©
¾ËÄÚµò¿¬Áúݼ¿ - »õâ
¿µÀÏÁ¦¾à
A16604021 Vaccinium myrtillus extract
ÀϹÝÀǾàǰ | ±Þ¿©
À¯´Ï¾Ë¿¡ÇÁ¿¬Áúݼ¿ - »õâ
À¯´Ï¸ÞµåÁ¦¾à
A50752651 Vaccinium myrtillus extract
ÀϹÝÀǾàǰ | ±Þ¿©
¾ÆÀ̵ò¿¬Áúĸ½¶ - »õâ
´ë¿ì¾àǰ°ø¾÷
A05454811 Vaccinium myrtillus extract
ÀϹÝÀǾàǰ | ±Þ¿©
¾ÆÀ̺ñÄÞ¿¬Áúĸ½¶ - »õâ
¹ÙÀ̳ؽº
A04851781 Vaccinium myrtillus extract
ÀϹÝÀǾàǰ | »èÁ¦
Å¥·¹Æ¾¿¬Áúݼ¿ - »õâ
ÅÂÁØÁ¦¾à
A28350781 Vaccinium myrtillus extract
ÀϹÝÀǾàǰ | ±Þ¿©
¾ÆÀÌ´ÙÁ¸¿¬Áúĸ½¶ - »õâ
¹Ì·¡Á¦¾à
A20652941 Vaccinium myrtillus extract
ÀϹÝÀǾàǰ | ±Þ¿©
¸ð¾ÆÆ®·Ð¿¬Áúĸ½¶ - »õâ
űؾàǰ°ø¾÷
A08651861 Vaccinium myrtillus extract
ÀϹÝÀǾàǰ | ±Þ¿©
µð¾ÆÀÌ¿¬Áúĸ½¶ - »õâ
Å©¶ó¿îÁ¦¾à
A31051311 Vaccinium myrtillus extract
ÀϹÝÀǾàǰ | ±Þ¿©
Å¥·¹Æ¾Á¤ - »õâ
ÅÂÁØÁ¦¾à
A28302561 Vaccinium myrtillus extract
ÀϹÝÀǾàǰ | ±Þ¿©
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
vaccinee a patient who has been vaccinated
Ãâó: wordnet.princeton.edu/perl/webwn
vacuolate formed into or containing one or more vacuoles or small membrane-bound cavities within a cell
Ãâó: wordnet.princeton.edu/perl/webwn
vaccinia a local infection induced in humans by inoculation with the virus causing cowpox in order to confer resistance to smallpox; normally lasts three weeks and leaves a pitted scar cowpox: a viral disease of cattle causing a mild skin disease affecting the udder; formerly used to inoculate humans against smallpox
Ãâó: wordnet.princeton.edu/perl/webwn
Vaccinium macrocarpon American cranberry: trailing red-fruited plant
Ãâó: wordnet.princeton.edu/perl/webwn
vacuolated vacuolate: formed into or containing one or more vacuoles or small membrane-bound cavities within a cell
Ãâó: wordnet.princeton.edu/perl/webwn
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • vaccillant
    =VACILLATING
  • vaccinal
    ¹é½Å(¿ìµÎ)ÀÇ
  • vaccinate
    ¿¹¹æÁֻ縦 ³õ´Ù
  • vaccinate
    ¿ìµÎ¸¦ Á¢Á¾ÇÏ´Ù;¹é½Å ÁÖ»ç(¿¹¹æ Á¢Á¾) ÇÏ´Ù
  • vaccination
    ¿ÎÂð ÁÖ»ç
  • vaccination
    ¹é½Å(¿¹¹æ)Á¢Á¾;Á¾µÎ;Á¾µÎ ÀÚ±¹
  • vaccinator
    Á¾µÎ ÀÇ»ç;¿ìµÎÄ®;Á¢Á¾ ÁÖ»ç±â
  • vaccine
    ¿ìµÎÁ¾
  • vaccine
    ¿ìµÎÁ¾;¹é½Å
  • vaccinee
    ¹é½Å ÁÖ»ç(Á¾µÎ)¸¦ ¸ÂÀº »ç¶÷
  • vaccinia
    ¿ìµÎÁ¾;¹é½Å
  • vaccinization
    ¿¬¼Ó Á¾µÎ(¸é¿ªÀÌ µÉ ¶§±îÁöÀÇ)
  • vacillate
    Èçµé¸®´Ù
  • vacillate
    µ¿¿äÇÏ´Ù;(¸¶À½,»ý°¢ÀÌ)Èçµé¸®´Ù
  • vacillating
    µ¿¿äÇÏ´Â
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 12 ÆäÀÌÁö: 2
VAC leisure time away from work
VAC spend or take a vacation
VAC a dwelling (a second home) where you live while you are on vacation
VAC an area where many people go for recreation
VAC someone on vacation
VAC the act of taking a vacation
VAC someone on vacation
VAC cow-cockles
VAC European annual with pale rose-colored flowers
VAC European annual with pale rose-colored flowers
VAC perfomr vaccinations or produce immunity in by inoculation
VAC having been rendered unsusceptible to a disease
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 5 ÆäÀÌÁö: 2
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á